Carcinoma in situ of the vagina is a non-invasive malignancy characterized by abnormal cell growth confined to the vaginal epithelium. It is often associated with human papillomavirus (HPV) infection and requires careful monitoring due to its potential progression to invasive cancer. The ICD-10 Code D07.2 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate management and treatment strategies are implemented.
ICD-10 Code D07.2 specifically denotes carcinoma in situ of the vagina, indicating the presence of abnormal cells that have not invaded surrounding tissues. This code is essential for clinical documentation and billing, particularly when diagnosing patients with precancerous lesions that may require further intervention or monitoring.
Carcinoma in situ of the vagina arises from the vaginal epithelium and is primarily linked to HPV infection. It is crucial to identify and treat this condition promptly to prevent progression to invasive cancer. Regular screening and follow-up are essential for affected patients.
ICD-10 Code D07.2 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of the vagina, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code D07.2 connects subjective patient reports and objective clinical findings to a formal diagnosis of carcinoma in situ of the vagina. This code is crucial for ensuring continuity of care, supporting billing processes, and meeting EHR documentation standards.
Prompt treatment of carcinoma in situ of the vagina is essential to prevent progression to invasive cancer. Surgical intervention is typically the primary approach.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D07.2 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims for carcinoma in situ of the vagina.
| CPT Code | Description |
|---|---|
| 58150 | Total abdominal hysterectomy, with or without salpingo-oophorectomy. |
| 57460 | Colposcopy of the vagina. |
| 88305 | Pathology examination of tissue, including biopsy. |
Common Questions About Using ICD-10 Code D07.2 for Carcinoma in situ of vagina
What are the risk factors for carcinoma in situ of the vagina?
Risk factors include HPV infection, particularly high-risk types, a history of cervical dysplasia, and immunosuppression. Regular screening is essential for early detection.
How is carcinoma in situ of the vagina diagnosed?
Diagnosis typically involves a pelvic examination, Pap smear, and biopsy to confirm the presence of abnormal cells confined to the vaginal epithelium.
What treatment options are available for carcinoma in situ of the vagina?
Treatment primarily involves surgical excision of the affected tissue. Regular follow-up and monitoring are also crucial to prevent progression to invasive cancer.
Is carcinoma in situ of the vagina contagious?
No, carcinoma in situ is not contagious. However, HPV, which can lead to this condition, is a sexually transmitted infection.
Clinical Notes
SOAP notes
DAP notes
AI medical notes